C P Mavragani
Overview
Explore the profile of C P Mavragani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argyropoulou O, Pezoulas V, Chatzis L, Critselis E, Gandolfo S, Ferro F, et al.
Semin Arthritis Rheum
. 2020 Sep;
50(5):846-853.
PMID: 32896698
Objective: To describe the clinical spectrum of cryoglobulinemic vasculitis (CV) in primary Sjögren's syndrome (pSS), investigate its relation to lymphoma and identify the differences with hepatitis C virus (HCV) related...
2.
Ekholm L, Vosslamber S, Tjarnlund A, de Jong T, Betteridge Z, McHugh N, et al.
Scand J Immunol
. 2016 May;
84(2):100-9.
PMID: 27173897
Myositis is a heterogeneous group of autoimmune diseases, with different pathogenic mechanisms contributing to the different subsets of disease. The aim of this study was to test whether the autoantibody...
3.
Voulgarelis M, Mavragani C, Xu L, Treon S, Moutsopoulos H
Genes Immun
. 2013 Oct;
15(1):54-6.
PMID: 24153350
Sjogren's syndrome (SS) is a chronic autoimmune disorder with the highest risk for lymphoma development among all autoimmune diseases. In order to evaluate whether the presence of the recently described...
4.
Danielides S, Mavragani C, Katsakoulas I, Zintzaras E, Drosos A, Vlachoyiannopoulos P, et al.
Scand J Rheumatol
. 2011 Mar;
40(4):299-303.
PMID: 21417550
Objectives: Thyroid dysfunction in the setting of systemic sclerosis (SSc) has been described previously. We aimed to determine the prevalence of anti-thyroid antibodies (ATA) in a large SSc cohort and...
5.
Mavragani C, Danielides S, Zintzaras E, Vlachoyiannopoulos P, Moutsopoulos H
Lupus
. 2009 Sep;
18(12):1096-9.
PMID: 19762385
Autoimmune thyroid disease has been associated with several systemic autoimmune disorders. However, limited data are available regarding the prevalence and clinical associations of thyroid autoimmunity in antiphospholipid syndrome (APS). Seventy-five...
6.
Karageorgaki Z, Bertsias G, Mavragani C, Kritikos H, Spyropoulou-Vlachou M, Drosos A, et al.
Clin Exp Rheumatol
. 2009 Aug;
27(1 Suppl 52):S33-9.
PMID: 19646344
Objective: Takayasu arteritis (TA) is an uncommon disease with clinical heterogeneity across different ethnic groups. We aimed to evaluate the epidemiological, clinical, and immuno-genetic features of TA in Greece. Methods:...
7.
Cantaert T, De Rycke L, Mavragani C, Wijbrandts C, Niewold T, Niers T, et al.
Ann Rheum Dis
. 2008 Jul;
68(6):1022-9.
PMID: 18625621
Objective: Type I interferons and apoptotic particles contribute to antinuclear autoimmunity in experimental models. This study assessed whether similar mechanisms contribute to break peripheral B-cell tolerance in humans by studying...
8.
Karaiskos D, Mavragani C, Makaroni S, Zinzaras E, Voulgarelis M, Rabavilas A, et al.
Ann Rheum Dis
. 2008 Feb;
68(1):40-6.
PMID: 18276740
Objectives: Previous evidence suggests the role of psychological stress in triggering the onset of autoimmunity. We aimed to investigate whether stress following major and minor life events could precede the...
9.
Dastmalchi M, Grundtman C, Alexanderson H, Mavragani C, Einarsdottir H, Helmers S, et al.
Ann Rheum Dis
. 2008 Feb;
67(12):1670-7.
PMID: 18272672
Objective: To investigate the effect of the tumour necrosis factor (TNF) blocking agent infliximab in patients with treatment-resistant inflammatory myopathies. Methods: A total of 13 patients with refractory polymyositis (PM),...
10.
Mavragani C, Batziou K, Aroni K, Pikazis D, Manoussakis M
Ann Rheum Dis
. 2005 Sep;
64(10):1521-2.
PMID: 16162909
No abstract available.